Leading pharma companies are setting targets for reducing their greenhouse gas emissions, and reporting on their progress in meeting them. That’s according to a new study we at Oxford PharmaGenesis conducted in collaboration with researchers from the University of Oxford. But when it comes to reporting on supply chain emissions, more collaboration is needed – and the time is now.
Professor Gino Martini, CEO of the Precision Health Technologies Accelerator (PHTA Ltd), explains how Birmingham is providing the collaborative space to simultaneously drive innovation in pharma, and tackle health inequality.
For businesses operating in the pharmaceutical industry, patient safety is paramount and, when it comes to the labelling of products, devices or solutions used for medical purposes, clear, consistent and highly accurate labels are essential.